NEW YORK (GenomeWeb News) – Shares of Caliper Life Sciences closed down more than 12 percent in Monday trade on the Nasdaq in advance of the release of its second-quarter results on Wednesday.
 
As reported Friday by GenomeWeb Daily News, Caliper’s stock had gained around 53 percent in the month of July, after it had declined steadily through the first half of the year.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.